
Health
Drugmaker Mallinckrodt Reaches $1.6B Opioid Settlement
NEW YORK – The generic drugmaker Mallinckrodt has a tentative $1.6 billion deal to settle lawsuits over its role in the U.S. opioid crisis, it announced Tuesday. The deal is intended to end hundreds of …